Ken Yamazumi
Direktor/Vorstandsmitglied bei SanBio, Inc.
Profil
Ken Yamazumi is currently the Director & External Auditor at SanBio, Inc. He was previously the Chairman & President at Kirin Pharma Co. Ltd.
from 2007 to 2008, and the Representative Director & Executive Vice President at Kyowa Kirin Co., Ltd.
from 2011 to 2012.
Mr. Yamazumi received his undergraduate degree from the University of Tokyo in 1973.
Aktive Positionen von Ken Yamazumi
Unternehmen | Position | Beginn |
---|---|---|
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ken Yamazumi
Unternehmen | Position | Ende |
---|---|---|
KYOWA KIRIN CO. LTD. | Direktor/Vorstandsmitglied | 22.03.2012 |
Kirin Pharma Co. Ltd.
Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Vorsitzender | 06.10.2008 |
Ausbildung von Ken Yamazumi
University of Tokyo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
KYOWA KIRIN CO. LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Kirin Pharma Co. Ltd.
Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Health Technology |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |